Sign up
Log in
News
MBIO
0.3606
+3.18%
0.0111
Weekly Report: what happened at MBIO last week (0715-0719)?
Weekly Report · 4d ago
Mustang Bio files to sell 6.5M shares by holders
Seeking Alpha · 07/19 21:38
Weekly Report: what happened at MBIO last week (0708-0712)?
Weekly Report · 07/15 12:00
Mindbio Therapeutics CEO Issues Letter To Shareholders
MindBio has two currently dosing Phase 2B clinical trials of its lead candidate drug, MB22001. The drug is a psychedelic medicine approved for take home dosing in New Zealand. The Company is the only publicly listed company specializing in a scalable psychedelic microdosing treatment model.
Benzinga · 07/08 12:40
Weekly Report: what happened at MBIO last week (0701-0705)?
Weekly Report · 07/08 12:02
Mustang Bio Reclaims Assets After National Security Halt
TipRanks · 07/03 13:18
Weekly Report: what happened at MBIO last week (0624-0628)?
Weekly Report · 07/01 12:03
Weekly Report: what happened at MBIO last week (0617-0621)?
Weekly Report · 06/24 12:13
MUSTANG BIO ANNOUNCES CLOSING OF $2.5 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
Reuters · 06/21 20:01
Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Kaival Brands Innovations Group, Inc. Shares dipped 47% to $1.52 on Friday. The company announced pricing of $6.0 million public offering. American Rebel Holdings, Inc., shares jumped 161% in today's mid-day session. Other stocks moving in the market included Spectaire Holdings, Sarepta Therapeutics and Clover Health Investments.
Benzinga · 06/21 18:04
Health Care Sector Update for 06/21/2024: SRPT, OCGN, MBIO, XLV, IBB
NASDAQ · 06/21 13:12
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Jabil Inc. Fell 7.8% to $116.37 on Thursday. Jabil reported third-quarter fiscal 2024 revenue of $6.77 billion, down 20.2% year-on-year. MGO Global, Inc. Shares jumped 222.8%.
Benzinga · 06/20 17:26
12 Health Care Stocks Moving In Thursday's Intraday Session
Molecular Partners stock rose 39.1% to $11.07 during Thursday's regular session. Zentalis Pharma (NASDAQ:ZNTL) shares rose 36.83% during the session. Femasys stock increased by 28.27% and SeaStar Medical Holding shares rose 18.68%.
Benzinga · 06/20 16:32
Mustang Bio announces $2.5M registered direct offering
Mustang Bio announces $2.5M registered direct offering. The offering is expected to close on or about June 21, 2024. The company intends to use the net proceeds from the offering for working capital and general corporate purposes. Mustang Bio, Inc. (MBIO) Stock
Seeking Alpha · 06/20 14:08
Dow Edges Lower; US Current Account Deficit Widens In Q1
U.S. Stocks traded mixed on Thursday. The Dow traded down 0.10% to 38,795.35 while the NASDAQ rose 0.16%. The S&P 500 gained around 0.1% on Thursday after the market opened. MGO Global, Inc. Shares shot up 236% after the company announced acquisition of Spetner Associates. The U.S current account deficit rose by $15.8 billion to $237.6 billion in first quarter.
Benzinga · 06/20 13:42
BUZZ-U.S. STOCKS ON THE MOVE-Dell, Hewlett Packard Enterprise, Accenture
The S&P 500 and the Nasdaq were on track to open higher on Thursday. Nvidia rallies as investors firm up bets on interest rate cuts this year. Dell, Hewlett Packard Enterprise, Accenture are among the top stocks on the move. Dow e-minis were down 0.12% in early trading.
Reuters · 06/20 13:22
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Tempest Therapeutics (NASDAQ:TPST) shares rose 32.8% to $3.79 during Thursday's pre-market session. Neurogene shares rose 31.92% during the session. Geovax Labs and SAB Biotherapeutics also rose. Mustang Bio stock fell 27.4% in the same session.
Benzinga · 06/20 12:05
Press Release: Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Dow Jones · 06/20 12:00
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Thursday. SMX (Security Matters) stock is rocketing more than 100% alongside heavy pre-market trading. Study data, acquisition updates, a secondary stock offering and more are moving stocks this morning. 10 Top Gainers: SMX stock is soaring over 50% with new study data.
Investorplace · 06/20 11:28
3 Penny Stocks to Watch Now, 6/20/24
TipRanks · 06/20 09:48
More
Webull provides a variety of real-time MBIO stock news. You can receive the latest news about Mustang Bio through multiple platforms. This information may help you make smarter investment decisions.
About MBIO
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating medical breakthroughs in cell and gene therapies into potential cures for cancers and rare genetic diseases. The Company has partnered with medical institutions to advance the development of chimeric antigen receptor modified T cell (CAR-T) therapies across multiple cancers, as well as lentiviral gene therapies for severe combined immunodeficiency. Its pipeline is focused in three core areas: CAR T therapies for hematologic malignancies, CAR T therapies for solid tumors and gene therapies for rare genetic disorders. It is developing a CAR T therapy for hematologic malignancies in partnership with Fred Hutch targeting CD20 (MB-106). In partnership with St. Jude, its X-linked Severe Combined Immunodeficiency (XSCID) gene therapy programs (MB-117 and MB-217) are being developed under an exclusive license to develop a potentially curative treatment for XSCID, a rare genetic immune system condition.